These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 36202866)
1. The current status of chronic kidney disease-mineral and bone disorder management in China. Zhan Y; He X; Hong D; Wang L; Li G Sci Rep; 2022 Oct; 12(1):16694. PubMed ID: 36202866 [TBL] [Abstract][Full Text] [Related]
2. Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China. Tao S; Li X; Liu Z; Bai Y; Qian G; Wu H; Li J; Guo Y; Yang S; Chen L; Yang J; Han J; Ma S; Yang J; Yu L; Shui R; Jin X; Wang H; Zhang F; Chen T; Li X; Zong X; Liu L; Fan J; Wang W; Zhang Y; Shi G; Wang D Int Urol Nephrol; 2023 Feb; 55(2):389-398. PubMed ID: 35951256 [TBL] [Abstract][Full Text] [Related]
3. Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study. Dang ZH; Tang C; Li GL; Luobu C; Qing D; Ma ZH; Qu JF; Suolang L; Liu LJ Ren Fail; 2019 Nov; 41(1):636-643. PubMed ID: 31269846 [No Abstract] [Full Text] [Related]
4. Serum 25-Hydroxyvitamin D Level Is Negatively Associated with Fatigue in Elderly Maintenance Hemodialysis Patients. Pang M; Chen L; Jiang N; Jiang M; Wang B; Wang L; Jia XY Kidney Blood Press Res; 2023; 48(1):231-240. PubMed ID: 36882038 [TBL] [Abstract][Full Text] [Related]
5. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe]. Jean G; Daugas É; Roth H; Drueke T; Bouchet JL; Hannedouche T; London G; Fouque D Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391 [TBL] [Abstract][Full Text] [Related]
6. Achievements in CKD-MBD guidelines targets: is there a progress in the implementation practice? Spasovski G; Zdravkovska V; Zabzun M; Antarorov R; Ivanovski K; Janakievska P; Neskovski J; Karceva-Sarajlia E; Panova B; Petrovska T; Zulbeari L; Masin-Spasovska J; Taleska-Matovska N; Gelev S Int Urol Nephrol; 2012 Dec; 44(6):1791-8. PubMed ID: 22173961 [TBL] [Abstract][Full Text] [Related]
7. Etelcalcetide Utilization, Dosing Titration, and Chronic Kidney Disease-Mineral and Bone Disease (CKD-MBD) Marker Responses in US Hemodialysis Patients. Karaboyas A; Muenz D; Fuller DS; Desai P; Lin TC; Robinson BM; Rossetti S; Pisoni RL Am J Kidney Dis; 2022 Mar; 79(3):362-373. PubMed ID: 34273436 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of chronic kidney disease-mineral and bone disorder in incident peritoneal dialysis patients and its association with short-term outcomes. Chuang SH; Wong HC; Vathsala A; Lee E; How PP Singapore Med J; 2016 Nov; 57(11):603-609. PubMed ID: 26778726 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve? Weissheimer R; Bucharles SGE; Truyts CAM; Jorgetti V; Figueiredo AE; Barrett P; Olandoski M; Pecoits-Filho R; Moraes TP J Bras Nefrol; 2021; 43(2):173-181. PubMed ID: 33538758 [TBL] [Abstract][Full Text] [Related]
10. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Souqiyyeh MZ; Shaheen FA Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700 [TBL] [Abstract][Full Text] [Related]
11. Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD-MBD in maintenance hemodialysis patients. Jia XY; Wei K; Chen J; Xi LH; Kong XL; Wei Y; Wang L; Wang ZS; Liu YP; Liang LM; Xu DM J Bone Miner Metab; 2021 Nov; 39(6):1058-1065. PubMed ID: 34392464 [TBL] [Abstract][Full Text] [Related]
12. KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Isakova T; Nickolas TL; Denburg M; Yarlagadda S; Weiner DE; Gutiérrez OM; Bansal V; Rosas SE; Nigwekar S; Yee J; Kramer H Am J Kidney Dis; 2017 Dec; 70(6):737-751. PubMed ID: 28941764 [TBL] [Abstract][Full Text] [Related]
13. Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis. Yamada S; Tsuruya K; Kitazono T; Nakano T Clin Exp Nephrol; 2022 Jul; 26(7):613-629. PubMed ID: 35353283 [TBL] [Abstract][Full Text] [Related]
14. Effects of Plant-Based Protein Consumption on Kidney Function and Mineral Bone Disorder Outcomes in Adults With Stage 3-5 Chronic Kidney Disease: A Systematic Review. Burstad KM; Cladis DP; Wiese GN; Butler M; Hill Gallant KM J Ren Nutr; 2023 Nov; 33(6):717-730. PubMed ID: 37116624 [TBL] [Abstract][Full Text] [Related]
15. Association between CKD-MBD and mortality in older patients with advanced CKD-results from the EQUAL study. Magagnoli L; Cozzolino M; Caskey FJ; Evans M; Torino C; Porto G; Szymczak M; Krajewska M; Drechsler C; Stenvinkel P; Pippias M; Dekker FW; de Rooij ENM; Wanner C; Chesnaye NC; Jager KJ; Nephrol Dial Transplant; 2023 Oct; 38(11):2562-2575. PubMed ID: 37230954 [TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor 23 (FGF 23) and intact parathyroid hormone (iPTH) as markers of mineral bone disease among Nigerians with non-diabetic kidney disease. Raji YR; Ajayi SO; Adeoye AM; Amodu O; Tayo BO; Salako BL Afr Health Sci; 2022 Mar; 22(1):344-351. PubMed ID: 36032486 [TBL] [Abstract][Full Text] [Related]
17. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study. Neri L; Kreuzberg U; Bellocchio F; Brancaccio D; Barbieri C; Canaud B; Stuard S; Ketteler M Nephrol Dial Transplant; 2019 Apr; 34(4):682-691. PubMed ID: 30165528 [TBL] [Abstract][Full Text] [Related]
18. International variation in the management of mineral bone disorder in patients with chronic kidney disease: Results from CKDopps. Liabeuf S; McCullough K; Young EW; Pisoni R; Zee J; Reichel H; Pecoits-Filho R; Port FK; Stengel B; Csomor PA; Metzger M; Robinson B; Massy ZA Bone; 2019 Dec; 129():115058. PubMed ID: 31493530 [TBL] [Abstract][Full Text] [Related]
19. Effect of CKD-MBD phenotype on health-related quality of life in patients receiving maintenance hemodialysis: A cross-sectional study. Luo L; Chen Q J Int Med Res; 2020 Feb; 48(2):300060519895844. PubMed ID: 32054360 [TBL] [Abstract][Full Text] [Related]
20. Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines. Liu Y; Lee WC; Cheng BC; Li LC; Lee CH; Chang WX; Chen JB Biomed Res Int; 2016; 2016():1523124. PubMed ID: 28003998 [No Abstract] [Full Text] [Related] [Next] [New Search]